Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Crunchbase
Centivo Secures $34M Series B To Scale Self-funded Employer Health Plan
December 7, 2020 -
PR Newswire
Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
December 7, 2020 -
GlobeNewswire
Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
December 4, 2020 -
GlobeNewswire
Adagene Announces Expansion of Leadership Team to Support Strategic Growth
December 2, 2020 -
Business Wire
Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating RIVAL-01 For the Treatment of Solid Tumors
December 1, 2020 -
PR Newswire
Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
December 1, 2020 -
PR Newswire
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
November 22, 2020 -
FierceBiotech
Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
November 20, 2020 -
GlobeNewswire
Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
November 19, 2020 -
Business Wire
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
November 18, 2020 -
GlobeNewswire
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH
November 16, 2020 -
PR Newswire
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
November 15, 2020 -
GlobeNewswire
Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
November 13, 2020 -
GlobeNewswire
Beam Therapeutics Presents First Data Highlighting Base Editing Program for Glycogen Storage Disease Type Ia at AASLD
November 13, 2020 -
Business Wire
Xilio Therapeutics Presents Promising Preclinical Tumor-Selective Efficacy and Safety Data for XTX201 (IL-2) and XTX101 (anti-CTLA-4) at SITC
November 12, 2020 -
Business Wire
Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
November 10, 2020 -
PR Newswire
PatientPing Partners with MedAllies to Ensure Hospital Partners’ Compliance with CMS E-Notifications Condition of Participation
November 10, 2020 -
GlobeNewswire
Denali Therapeutics Announces First Human Biomarker Proof of Concept for Its Transport Vehicle (TV) Technology Achieved in Phase 1/2 Study of ETV:IDS (DNL310) in Hunter Syndrome (MPS II)
November 10, 2020 -
PR Newswire
Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020
November 10, 2020 -
GlobeNewswire
Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
November 9, 2020 -
PR Newswire
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
November 9, 2020 -
GlobeNewswire
Beam Therapeutics Names First CAR-T Base Editing Development Candidate for the Treatment of T-ALL and Presents New Data at SITC 2020
November 9, 2020 -
GlobeNewswire
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
November 5, 2020 -
GlobeNewswire
Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020
November 4, 2020 -
PR Newswire
Sana Biotechnology Announces Acquisition of Oscine
October 30, 2020 -
Endpoints News
Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem
October 28, 2020 -
Business Wire
Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience
October 27, 2020 -
PR Newswire
Apricus Health Partners with Medicare Advantage Plan Devoted Health and Full-Service Retail Pharmacy Liton Rx
October 27, 2020 -
PR Newswire
Arcadia Expands Partnership with PatientPing, Enhancing Access to Real-Time Patient Data for Healthcare Organizations
October 27, 2020 -
The Irish Sun
Irish device that kills 99.999 per cent of Covid in air ‘could help end lockdown’ and get businesses open
October 26, 2020 -
GlobeNewswire
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy
October 23, 2020 -
GlobeNewswire
Orchard Therapeutics CEO Bobby Gaspar, M.D., Ph.D., Appointed to the Alliance for Regenerative Medicine’s 2021 Board of Directors
October 22, 2020 -
FierceBiotech
Compass aims at $50M IPO to push lead antibody through the clinic
October 20, 2020 -
PR Newswire
TraceLink Announces New Serialized Product Intelligence Solution
October 20, 2020 -
PR Newswire
PatientPing Commends Its Community of MSSP Accountable Care Organizations for Generating Over $517 Million in Shared Savings – a 20% Improvement Over Last Year
October 20, 2020 -
PR Web
Devoted Health Launches Compassionate, Affordable Medicare Advantage Plans in Arizona
October 20, 2020 -
Business Wire
Wellframe Partners with ZeOmega to Help Health Plans Offer an Enhanced Digital Experience
October 19, 2020 -
GlobeNewswire
Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
October 16, 2020 -
GlobeNewswire
Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial
October 15, 2020 -
PR Newswire
Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery
October 15, 2020 -
ACN News
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
October 13, 2020 -
PR Newswire
Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA® (Rituximab Injection) in China
October 9, 2020 -
GlobeNewswire
Denali Therapeutics Announces Closing of Collaboration and Share Purchase Agreements with Biogen
October 7, 2020 -
Business Wire
Caribou Biosciences Co-Founder Dr. Jennifer Doudna Awarded Nobel Prize in Chemistry
October 7, 2020 -
GlobeNewswire
Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US
October 6, 2020 -
PR Newswire
Applied BioMath, LLC Announces Two-Year Strategic Partnership with Xilio Therapeutics
October 5, 2020 -
PR Newswire
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
October 5, 2020 -
Business Wire
Xilio Therapeutics Appoints Rachel Humphrey, M.D. to Board of Directors
September 29, 2020 -
GlobeNewswire
Orchard Therapeutics Receives EMA PRIME Designation for OTL-203 for the Treatment of MPS-I
September 28, 2020 -
GlobeNewswire
Beam Therapeutics Announces Proposed Public Offering of Common Stock
September 28, 2020 -
PR Newswire
Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
September 25, 2020 -
BioPharma Journal
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma
September 25, 2020 -
PR Newswire
Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT™ (avapritinib) in Patients with Advanced Systemic Mastocytosis
September 22, 2020 -
GlobeNewswire
Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
September 21, 2020 -
PR Newswire
Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
September 21, 2020 -
PR Newswire
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
September 21, 2020 -
PR Newswire
Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO™ (Pralsetinib) in Patients with Advanced RET-Mutant Medullary Thyroid Cancer
September 20, 2020 -
PR Newswire
Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resistant EGFR-Mutated Lung Cancer at ESMO Virtual Congress 2020
September 17, 2020 -
GlobeNewswire
Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
September 17, 2020 -
Business Wire
Wellframe’s Melissa Herman Named 2020 CFO of the Year by Boston Business Journal
September 15, 2020 -
PR Newswire
Carrot Fertility Partners with CCRM Fertility Expanding Member Access to High-Quality Fertility Care
September 15, 2020 -
PR Newswire
Innovent and Lilly Jointly Announce Results of Six Clinical Studies of TYVYT® (sintilimab injection) to be Presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
September 14, 2020 -
News Medical Life Sciences
Insilico Medicine launches new system for COVID-19 basic and clinical research
September 9, 2020 -
GlobeNewswire
Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A, an Investigational Allogeneic CAR T Therapy for Relapsed/Refractory Multiple Myeloma
September 9, 2020 -
GlobeNewswire
Conduent Teams Up with Buoy Health and IBM Watson Health to Help its Clients Manage COVID-19 Related Workplace Challenges
September 9, 2020 -
PR Newswire
Avidity Biosciences Enters into Collaboration to Study the Natural History of Myotonic Dystrophy Type 1
September 8, 2020 -
Business Wire
Caribou Biosciences Announces FDA Clearance of its IND for CB-010, an Off-the-shelf Allogeneic Anti-CD19 CAR-T Cell Therapy
September 8, 2020 -
STAT
Blueprint Medicines wins U.S. approval for genetically targeted lung cancer drug
September 5, 2020 -
PR Newswire
Innovent Announces NMPA Granted Marketing Approval for SULINNO® (Adalimumab Injection) in China
September 3, 2020 -
PR Newswire
Sana Biotechnology Strengthens Senior Research Leadership Team with Ed Rebar, Ph.D. and Terry Fry, M.D.
September 3, 2020 -
Business Wire
Rallybio Appoints Helen M. Boudreau to Board of Directors
September 3, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Additional Interim Results from Proof-of-Concept Study of OTL-203 for MPS-I
September 1, 2020 -
PR Newswire
Nocion Therapeutics Advances to Clinical Stage and Expands Leadership
September 1, 2020 -
PR Newswire
Innovent Announces First Subject Dosed in the Phase 1 Clinical Trial of Anti-IL-23 Monoclonal Antibody
August 31, 2020 -
PR Newswire
Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO
August 31, 2020 -
PR Newswire
Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference
August 30, 2020 -
The Irish Times
Irish company among tech firms at forefront of fight against coronavirus
August 27, 2020 -
PR Newswire
EY Announces Nick Culbertson of Protenus as an Entrepreneur of the Year® 2020 Mid-Atlantic Award Finalist
August 27, 2020 -
PR Newswire
MedGenome announces Strategic Collaboration in Parkinson’s Disease with Denali Therapeutics
August 26, 2020 -
Business Wire
Compass Therapeutics Announces Publication in the Journal Science of Preclinical Data Supporting the Potential of CTX-2026, a Novel Antibody to the Butyrophilin BTN3A1, in Ovarian Cancer Tumor Models
August 24, 2020 -
Business Wire
Lyniate and PatientPing Form Strategic Partnership to Ensure Compliance with the CMS E-Notifications Requirements
August 19, 2020 -
GlobeNewswire
Precision BioSciences Receives Fast Track Disease Designation from U.S. Food and Drug Administration for PBCAR0191 Investigational Allogeneic CAR T Cell Therapy
August 19, 2020 -
PR Newswire
Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing Agreement
August 18, 2020 -
Business Wire
Ivenix Features Smart Pump Interoperability with Epic, Advancing Patient Outcomes and Clinical Efficiency
August 18, 2020 -
Fortune
Carrot Fertility closes $24 million Series B in a sign of the sector’s strength
August 18, 2020 -
PR Newswire
Buoy Health Selected as Preferred Partner in AI Enhanced Symptom Checker/ Digital Front Door Category by Consortium Health Plans
August 17, 2020 -
Business News Asia
Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
August 17, 2020 -
GlobeNewswire
Arvelle Announces Partnership with Durbin Across Europe
August 17, 2020 -
PR Newswire
Buoy Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
August 13, 2020 -
GlobeNewswire
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second Quarter 2020 Results
August 12, 2020
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.